[1]
D. Xu, X. Meng, Y. Yi, and Y. Zhao, “Data Asset Value Evaluation Model of H Pharmaceutical Enterprise”, FBEM, vol. 20, no. 3, pp. 145–149, Sep. 2025, doi: 10.54097/s16njg32.